Vicarious Surgical (RBOT) Other Non-Current Liabilities (2020 - 2025)
Vicarious Surgical's (RBOT) quarterly Other Non-Current Liabilities came in at $553000.0 in Q3 2025, down 55.58% year-on-year from $1.2 million in Q3 2024, and down 34.17% on a QoQ basis from $840000.0 in Q2 2025.
Vicarious Surgical (RBOT) Other Non-Current Liabilities (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has 6 years of Other Non-Current Liabilities data on file, last reported at $553000.0 in Q3 2025.
- On a quarterly basis, Other Non-Current Liabilities fell 55.58% year-over-year to $553000.0 in Q3 2025; TTM through Sep 2025 was $553000.0, a 55.58% decrease from a year earlier, with the FY2024 full-year figure at $787000.0, down 5.18% from the prior year.
- Other Non-Current Liabilities for Q3 2025 stood at $553000.0, down from $840000.0 in the prior quarter.
- Over the last five years, Other Non-Current Liabilities for RBOT reached as high as $129.6 million in Q3 2021 and fell as low as $553000.0 in Q3 2025.
- Historically, Other Non-Current Liabilities has averaged $20.7 million across 5 years, with a median of $6.0 million in 2022.
- Across the five-year window, Other Non-Current Liabilities jumped 206.03% in 2021 and plunged 93.31% in 2022, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $90.0 million in 2021, then plunged by 93.31% to $6.0 million in 2022, then plunged by 86.21% to $830000.0 in 2023, then decreased by 5.18% to $787000.0 in 2024, then fell by 29.73% to $553000.0 in 2025.
- Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $553000.0 in Q3 2025, $840000.0 in Q2 2025, and $880000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Vicarious Surgical | 654,984.55 | -9.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 553,000.00 |
| Jun 30, 2025 | 840,000.00 |
| Mar 31, 2025 | 880,000.00 |
| Dec 31, 2024 | 787,000.00 |
| Sep 30, 2024 | 1.25 Mn |
| Jun 30, 2024 | 1.11 Mn |
| Mar 31, 2024 | 2.70 Mn |
| Dec 31, 2023 | 830,000.00 |
| Sep 30, 2023 | 2.32 Mn |
| Jun 30, 2023 | 7.02 Mn |
| Mar 31, 2023 | 12.10 Mn |
| Dec 31, 2022 | 6.02 Mn |
| Sep 30, 2022 | 14.73 Mn |
| Jun 30, 2022 | 11.69 Mn |
| Mar 31, 2022 | 29.29 Mn |
| Dec 31, 2021 | 90.02 Mn |
| Sep 30, 2021 | 129.64 Mn |
| Jun 30, 2021 | 50.71 Mn |
| Mar 31, 2021 | 31.14 Mn |
| Dec 31, 2020 | 29.42 Mn |